Skip to main content
Caplight Logo









Cleara Biotech

Cleara Biotech

Private
UtrechtHealthcare & Life Scienceshttps://www.clearabiotech.com/

Last Round

Seed

Sep 28, 2022

Total Funding Raised

$2.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cleara Biotech is a biotechnology company that develops peptide-based therapies to eliminate senescent cells for the treatment of cancer and chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

senolytic therapysenolyticanti-aging drugsenescent celldrug discoverylongevity biotechsmall-molecule compoundapoptosisoncology researchage-related diseasebiopharmaceuticalFOXO4preclinical developmenttherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cleara Biotech Comparables

Compare Cleara Biotech with similar companies based on industry and business-model similarity.

Cleara Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Numeric Biotech
87%
Deciduous Therapeutics
87%
StarkAge Therapeutics
86%

Cleara Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 28, 2022
SeedJul 6, 2018

Cleara Biotech Investors

Notable investors and investment history

Cleara Biotech investors
InvestorRounds
ROM Utrecht RegionSeed
Longevitytech.fundSeed
Infinitas CapitalConvertible Debt
Korify CapitalConvertible Debt
Curie CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 228% MoM.

  • Apr 20, 2026

    Monthly visitors increased 613% MoM.

Cleara Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cleara Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cleara Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersUtrecht
Employee Range10
Year Founded2018
Last FundingSep 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?